Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 15277255

Phase III randomized trial of doxorubicin + cisplatin versus doxorubicin + 24-h paclitaxel + filgrastim in endometrial carcinoma: a Gynecologic Oncology Group study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Ann Oncol
Publication date
2004 Aug
First author
Fleming GF

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Ann Oncol. 2004 Aug;15(8):1149-50. doi: 10.1093/annonc/mdh325.
    note
    Source null
    related pmid
    15277252
    relationship
    Comment in

Authors and identifiers

  1. name
    Fleming GF
    type
    Author
  2. name
    Filiaci VL
    type
    Author
  3. name
    Bentley RC
    type
    Author
  4. name
    Herzog T
    type
    Author
  5. name
    Sorosky J
    type
    Author
  6. name
    Vaccarello L
    type
    Author
  7. name
    Gallion H
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Fleming GF
    type
    Author
  2. name
    Filiaci VL
    type
    Author
  3. name
    Bentley RC
    type
    Author
  4. name
    Herzog T
    type
    Author
  5. name
    Sorosky J
    type
    Author
  6. name
    Vaccarello L
    type
    Author
  7. name
    Gallion H
    type
    Author
bibliography ids
  1. nci-bib-a9c6bf0d33b6cb9e45057cc0
book metadata
content sha256
a274b2851cdaaa2d98b09a9a5a8c4c9bac03e4af9f8649a18e62b5d9af6c1b06
document type
citation
dois
  1. 10.1093/annonc/mdh316
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:15277255
immutable id
pubmed:15277255@a274b2851cdaaa2d98b09a9a5a8c4c9bac03e4af9f8649a18e62b5d9af6c1b06
journal
abbreviation
Ann Oncol
issn electronic
Source null
issn print
0923-7534
issue
8
name
Annals of oncology : official journal of the European Society for Medical Oncology
nlm unique id
9007735
pages
1173-8
volume
15
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Ann Oncol. 2004 Aug;15(8):1149-50. doi: 10.1093/annonc/mdh325.
    note
    Source null
    related pmid
    15277252
    relationship
    Comment in
outcomes validated
false
pmid
15277255
provenance
batch id
748437a772c9631ad901
provider
NCBI PubMed ESummary
record sha256
fc90b5f895ab6d76bc566cf7a374ca5439702f581ab1ebc7bf6c25c9cf2501db
response sha256
1535c16de1ca2ef53b01ccf9e7709049035aa1b159955f06fbec3d1a0daddc80
retrieved at
2026-09-09T23:45:55.399079+00:00
publication date
display
2004 Aug
precision
month
year
2004
publication types
  1. Clinical Trial
  2. Clinical Trial, Phase III
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, U.S. Gov't, P.H.S.
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/15277255/
title
Phase III randomized trial of doxorubicin + cisplatin versus doxorubicin + 24-h paclitaxel + filgrastim in endometrial carcinoma: a Gynecologic Oncology Group study.

Preserved source evidence · Not medical advice